Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Mueller

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of Hepatology|July 16, 2005
GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infectionChristoph Sarrazin, Thomas Berg, Viola Weich, et al.
Journal of Hepatology|April 28, 2019
Combination therapy of sofosbuvir and ribavirin fails to clear chronic hepatitis E infection in a multivisceral transplanted patientMarten Schulz, C Patrick Papp, Claus-Thomas Bock, et al.
Polymers|April 10, 2019
Replication of Overmolded Orthopedic Implants with a Functionalized Thin Layer of Biodegradable PolymerAhmed Elkaseer, Tobias Mueller, Sabino Azcarate, et al.
Neurology. Genetics|October 20, 2018
Increased <i>KCNJ18</i> promoter activity as a mechanism in atypical normokalemic periodic paralysisMuhidien Soufi, Volker Ruppert, Susanne Rinné, et al.
Plos One|May 30, 2014
Gene expression profiles of human dendritic cells interacting with Aspergillus fumigatus in a bilayer model of the alveolar epithelium/endothelium interfaceCharles Oliver Morton, Mirjam Fliesser, Marcus Dittrich, et al.
Genetic Testing and Molecular Biomarkers|May 29, 2009
Evaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologiesJuliane Halangk, Thomas Berg, Konrad Neumann, et al.
Hepatology (Baltimore, Md.)|September 16, 2004
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis CHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
Journal of Clinical Medicine|May 14, 2022
Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing CholangitisBurcin Özdirik, Martin Maibier, Maria Scherf, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2011
Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitisTobias Mueller, Claudia Beutler, Almudena Hurtado Picó, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 16, 2003
CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophiliaHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Hepatology|July 16, 2005
GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infectionChristoph Sarrazin, Thomas Berg, Viola Weich, et al.
Journal of Hepatology|April 28, 2019
Combination therapy of sofosbuvir and ribavirin fails to clear chronic hepatitis E infection in a multivisceral transplanted patientMarten Schulz, C Patrick Papp, Claus-Thomas Bock, et al.
Polymers|April 10, 2019
Replication of Overmolded Orthopedic Implants with a Functionalized Thin Layer of Biodegradable PolymerAhmed Elkaseer, Tobias Mueller, Sabino Azcarate, et al.
Neurology. Genetics|October 20, 2018
Increased <i>KCNJ18</i> promoter activity as a mechanism in atypical normokalemic periodic paralysisMuhidien Soufi, Volker Ruppert, Susanne Rinné, et al.
Plos One|May 30, 2014
Gene expression profiles of human dendritic cells interacting with Aspergillus fumigatus in a bilayer model of the alveolar epithelium/endothelium interfaceCharles Oliver Morton, Mirjam Fliesser, Marcus Dittrich, et al.
Genetic Testing and Molecular Biomarkers|May 29, 2009
Evaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologiesJuliane Halangk, Thomas Berg, Konrad Neumann, et al.
Hepatology (Baltimore, Md.)|September 16, 2004
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis CHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
Journal of Clinical Medicine|May 14, 2022
Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing CholangitisBurcin Özdirik, Martin Maibier, Maria Scherf, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2011
Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitisTobias Mueller, Claudia Beutler, Almudena Hurtado Picó, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 16, 2003
CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophiliaHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
Pageof 6